Located in Rockville, Maryland, GSK's Human Genome Sciences will be Samsung Biologics' first U.S.-based manufacturing site. | ...

Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making ...

SEOUL, Dec 22 (Reuters) - South Korea's Samsung Biologics (207940.KS) said on Monday it is acquiring its first U.S. drug ...

Samsung Biologics has signed a contract to acquire the U.S. biopharmaceutical production facility of GSK, a global ...

While the United Kingdom feted President Trump in his second state visit, GSK said Wednesday it will spend $30 billion over the next five years to build new manufacturing and research facilities ...

British Big Pharma GSK is welcoming President Donald Trump to the U.K. with a hefty gift: a five-year, $30 billion planned investment in U.S. R&D and manufacturing. The funds are set to be spread ...

GSK plc (NYSE:GSK) on Wednesday announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years. The update includes ...

GlaxoSmithKline does not know when it will resume producing Excedrin. Pharmaceutical giant GlaxoSmithKline has temporarily stopped production of Excedrin, its popular over-the-counter migraine ...

The Maryland life sciences campus is part of a package deal alongside Human Genome Sciences, which Samsung is acquiring from ...